These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1835399)

  • 1. New French studies of clodronate in cancer-induced osteolysis.
    Burki F
    Bone; 1991; 12 Suppl 1():S35. PubMed ID: 1835399
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of skeletal disease in breast cancer with clodronate.
    Paterson AH; Ernst DS; Powles TJ; Ashley S; McCloskey EV; Kanis JA
    Bone; 1991; 12 Suppl 1():S25-30. PubMed ID: 1720012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biphosphonates. Contribution to the treatment of malignant osteolysis].
    Prier A
    Presse Med; 1992 Jul 4-11; 21(25):1143-5. PubMed ID: 1409460
    [No Abstract]   [Full Text] [Related]  

  • 4. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
    Tubiana-Hulin M; Beuzeboc P; Mauriac L; Barbet N; Frenay M; Monnier A; Pion JM; Switsers O; Misset JL; Assadourian S; Bessa E
    Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role and use of biphosphonates in the treatment of metastatic breast cancer].
    Caulin F
    Pathol Biol (Paris); 1990 Oct; 38(8):862-3. PubMed ID: 2148817
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of Clodronate in the treatment of bone metastasis].
    Pouillart P; Beuzeboc P
    Bull Cancer; 1991; 78(8):737-41. PubMed ID: 1834287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Double-blind trial of oral clodronate in breast cancer patients with bone metastases].
    Paterson AH; Powles TJ; Kanis JA; McCloskey E; Hanson J; Ashley S
    Bull Cancer; 1993; 80(10 Suppl):50-6. PubMed ID: 8081032
    [No Abstract]   [Full Text] [Related]  

  • 8. Clodronate for osteolytic metastases due to breast cancer.
    Elomaa I; Blomqvist C; Porkka L; Holmström T; Taube T; Lamberg-Allardt C; Borgström GH
    Biomed Pharmacother; 1988; 42(2):111-6. PubMed ID: 2971403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clodronate and radiotherapy for the treatment of osteolysis caused by metastasis of breast carcinoma and non-small cell lung carcinoma. A retrospective study].
    Caristi N; Russi EG; Adamo V; Altavilla G; d'Aquino A; Delia P; Di Carlo M; Maisano R; Romeo F; Salvi L
    G Ital Oncol; 1990; 10(4):129-32. PubMed ID: 1965506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clodronate: the potential for the future.
    Powles T
    Bone; 1991; 12 Suppl 1():S43-4. PubMed ID: 1720014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of malignant hypercalcaemia with clodronate.
    Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
    Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clodronate and other bisphosphonates as supportive therapy in osteolysis due to malignancy.
    Elomaa I; Blomqvist C
    Acta Oncol; 1995; 34(5):629-36. PubMed ID: 7546830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of clodronate in multiple myeloma.
    Delmas PD
    Bone; 1991; 12 Suppl 1():S31-4. PubMed ID: 1835398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
    Paterson AH; Powles TJ; Kanis JA; McCloskey E; Hanson J; Ashley S
    J Clin Oncol; 1993 Jan; 11(1):59-65. PubMed ID: 8418243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clodronate in metastatic breast cancer.
    Panasci LC; Sandor V; Melnychuk D
    N Engl J Med; 1998 Dec; 339(26):1940-1; author reply 1941. PubMed ID: 9874608
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is pamidronate or clodronate better?].
    Adam Z
    Vnitr Lek; 2002 Apr; 48(4):357. PubMed ID: 12075601
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind, placebo-controlled, dose-response trial of oral clodronate in patients with bone metastases.
    O'Rourke N; McCloskey E; Houghton F; Huss H; Kanis JA
    J Clin Oncol; 1995 Apr; 13(4):929-34. PubMed ID: 7707121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of oral clodronate in the management of malignant osteolysis and hypercalcaemia.
    Aranko K; Hanhijärvi H; Humphreys M; Drake J; Lawton WA
    Bone; 1995 Feb; 16(2):275-8. PubMed ID: 7756058
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacologic therapy of bone tissue changes due to hematologic malignancies and bone metastasis].
    Kiełbiński M
    Acta Haematol Pol; 1994; 25(2):91-8. PubMed ID: 8067192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of dichloromethylene diphosphonate in metastatic bone disease.
    Jung A; Chantraine A; Donath A; van Ouwenaller C; Turnill D; Mermillod B; Kitler ME
    N Engl J Med; 1983 Jun; 308(25):1499-501. PubMed ID: 6222257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.